Quarterly report · Q3
4978.TEDINET S100Q5XB
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.2bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥2.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.5bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | −¥207m | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | −¥529m | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | −¥37m | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | −¥507m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥351m | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | −¥37m | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | −¥351m | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥39m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥575m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥351m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥39m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | −¥353m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥8.3bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥8.1bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥7.8bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥557m | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥845m | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.7bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥7.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.3bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.6bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-0.47 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.27 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.57 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.74 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.93 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 93.3% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.5% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.7% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment ordinary income | 2022-04-01 → 2022-12-31 | −¥440m |
| jpcrp040300-q3r_E27585-000Medical Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥866m |
| jpcrp040300-q3r_E27585-000Medical Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥866m |
| jpcrp040300-q3r_E27585-000Medical Businessreportable segment | segment ordinary income | 2022-04-01 → 2022-12-31 | ¥204m |
| jpcrp040300-q3r_E27585-000Research Support Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E27585-000Research Support Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E27585-000Research Support Businessreportable segment | segment ordinary income | 2022-04-01 → 2022-12-31 | ¥200m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥2.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥2.2bn |
| —segment total | segment ordinary income | 2022-04-01 → 2022-12-31 | ¥404m |
| Reconciling Itemsreconciling | segment ordinary income | 2021-04-01 → 2021-12-31 | −¥390m |
| jpcrp040300-q3r_E27585-000Medical Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥514m |
| jpcrp040300-q3r_E27585-000Medical Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥514m |
| jpcrp040300-q3r_E27585-000Medical Businessreportable segment | segment ordinary income | 2021-04-01 → 2021-12-31 | −¥50m |
| jpcrp040300-q3r_E27585-000Research Support Businessreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥975m |
| jpcrp040300-q3r_E27585-000Research Support Businessreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥975m |
| jpcrp040300-q3r_E27585-000Research Support Businessreportable segment | segment ordinary income | 2021-04-01 → 2021-12-31 | ¥89m |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥1.5bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥1.5bn |
| —segment total | segment ordinary income | 2021-04-01 → 2021-12-31 | ¥39m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 355
| Item | Context | Value | Unit |
|---|---|---|---|
| Income taxes deferred | Prior1YTDDuration | -131000 | JPY |
| Income taxes deferred | CurrentYTDDuration | － | JPY |
| Income taxes | Prior1YTDDuration | 1332000 | JPY |
| Income taxes | CurrentYTDDuration | 2924000 | JPY |
| Profit loss | Prior1YTDDuration | -352545000 | JPY |
| Profit loss | CurrentYTDDuration | -39491000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | -1214000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | － | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | -351331000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | -39491000 | JPY |
| Profit loss | Prior1YTDDuration | -352545000 | JPY |
| Profit loss | CurrentYTDDuration | -39491000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -33623000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | -40503000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 9462000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 12568000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1YTDDuration | 7206000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | CurrentYTDDuration | 1028000 | JPY |
| Other comprehensive income | Prior1YTDDuration | -16953000 | JPY |
| Other comprehensive income | CurrentYTDDuration | -26906000 | JPY |
| Comprehensive income | Prior1YTDDuration | -369498000 | JPY |
| Comprehensive income | CurrentYTDDuration | -66397000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | -368438000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | -66397000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | -1060000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | － | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E27585-000ResearchSupportBusinessReportableSegmentsMember | 974503000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E27585-000MedicalBusinessReportableSegmentsMember | 513669000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 1488173000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 1488173000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E27585-000ResearchSupportBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E27585-000MedicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E27585-000ResearchSupportBusinessReportableSegmentsMember | 974503000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E27585-000MedicalBusinessReportableSegmentsMember | 513669000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 1488173000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 1488173000 | JPY |
| Ordinary income | Prior1YTDDuration_jpcrp040300-q3r_E27585-000ResearchSupportBusinessReportableSegmentsMember | 89230000 | JPY |
| Ordinary income | Prior1YTDDuration_jpcrp040300-q3r_E27585-000MedicalBusinessReportableSegmentsMember | -50332000 | JPY |
| Ordinary income | Prior1YTDDuration_ReportableSegmentsMember | 38898000 | JPY |
| Ordinary income | Prior1YTDDuration_ReconcilingItemsMember | -390111000 | JPY |
| Ordinary income | Prior1YTDDuration | -351213000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E27585-000ResearchSupportBusinessReportableSegmentsMember | 1356901000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E27585-000MedicalBusinessReportableSegmentsMember | 866376000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 2223277000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |